持续和渐进的急性肺异位移植功能障碍与小呼吸道的细胞组成和转录性变化有关
Elsa Brunet-Ratnasingham1, Shivaram Yellamilli2, Ruyin Guo1
1Department of Medicine, University of California, San Francisco, San Francisco, California.
概括
渐进性急性肺异位移植功能障碍 (ALAD) 与气道细胞变化和基因表达改变有关. 识别这些分子模式可以预测哪些患者会发展慢性肺异位移植功能障碍 (CLAD).
科学领域:
- 肺部医学 肺部医学
- 移植免疫学 移植免疫学
- 单细胞基因组学 单细胞基因组学
背景情况:
- 急性肺异位功能障碍 (ALAD) 是移植后肺功能下降,可能表明慢性肺异位功能障碍 (CLAD) 发病.
- 目前的诊断工具缺乏准确性来识别高风险发展为CLAD的ALAD患者.
- 了解ALAD的细胞和转录变化对于向治疗至关重要.
研究的目的:
- 调查小气道细胞组成,转录特征和ALAD结果之间的关联.
- 识别分子标记物,以区分渐进的ALAD与恢复或稳定的全移植功能.
主要方法:
- 对肺移植接受者与未分化的ALAD和对照者的前性研究.
- 小气道刷毛,然后进行单细胞RNA测序.
- 对细胞组成,Reactome通路和AI2基因得分的分析与ALAD结果组 (恢复,持久,渐进) 相比.
主要成果:
- 小气道的细胞组成在ALAD结果组之间有显著差异.
- 更糟糕的ALAD结局与基底细胞减少,改变的俱乐部和状细胞,较少的巨细胞和更多的细胞毒性T细胞相关.
- AI2基因评分,特别是在上皮细胞中,以及干扰素信号的增加与较差的ALAD结果有关.
结论:
- 持续和渐进的ALAD与支气管细胞组成和转录程序的明显变化有关.
- 呼吸道细胞的分子表型学表明,有望识别患有ALAD的个体,患有进展到CLAD的风险更高.
- 这项试点研究强调了单细胞分析在理解和管理ALAD进展方面的潜力.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K


